Noticias de investigación
Ver artículos por meses y años
-
MBCS: Lumpectomy 'Safe' for Young Breast Cancer Patients (en inglés)
Early-stage breast cancer diagnosed in women age 40 and younger has a somewhat worse overall prognosis than early-stage breast cancer diagnosed in older women. Still, lumpectomy followed by radiation t...
-
Most Early Breast Cancer Patients Benefit From Adjuvant Therapy (en inglés)
"Systemic adjuvant therapy" are treatments -- hormonal therapy, chemotherapy, and targeted therapy -- given after breast cancer surgery to lower the risk of the cancer coming back (recurrence). The tre...
-
Computer Analysis of Mammograms No Help in Real-World (en inglés)
A very large study found that using computers to help read mammograms -- called computer-aided detection (CAD) -- didn't improve detection of either early-stage or advanced-stage breast cancers and inc...
-
Gene Test Referrals Often Ignore Guidelines (en inglés)
A study suggests that primary care doctors don't consistently recommend genetic testing for women at high risk for cancer because of family and personal history.
-
Hormone Thwarts Early Menopause in Breast Cancer (en inglés)
Chemotherapy is often used to treat breast cancer in both premenopausal and postmenopausal women. In premenopausal women, chemotherapy can disrupt normal ovary function and cause damage, which leads to...
-
Annual Mammogram Starting at 40 Gets ACOG Support (en inglés)
The American College of Obstetricians and Gynecologists (ACOG) has issued new breast cancer screening guidelines for doctors who care for women. The guidelines will be published in the August 2011 issu...
-
Patients' Family Cancer History Needs Regular Updating (en inglés)
A new study found that doctors and patients need to regularly talk about and update the patient's family history of cancer -- including breast cancer.
-
Survival Benefit with Mammography after 30 Years (en inglés)
A very large, long-term Swedish study found that women who had regular screening mammograms were 31% less likely to die of breast cancer over nearly 30 years compared to women who didn't get regular sc...
-
FDA Clears Improved HER2 Test in Breast Cancer (en inglés)
In June 2011, the U.S. Food and Drug Administration (FDA) approved a new test called Inform Dual ISH to determine the HER2 status of breast cancer cells. ISH stands for "in situ hybridization."
-
No Support for Thermography as Breast Screen (en inglés)
In June 2011, the U.S. Food and Drug Administration (FDA) warned doctors that thermography shouldn't be a substitute for mammograms and other proven breast imaging technology for screening and diagnosi...
